Dana–Farber Cancer Institute
Dana-Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
| Dana-Farber Cancer Institute | |
|---|---|
| Geography | |
| Location | 450 Brookline Avenue, Boston, Massachusetts, United States |
| Coordinates | 42.337637°N 71.108195°W |
| Organization | |
| Care system | Private |
| Funding | Non-profit hospital |
| Type | Specialist |
| Affiliated university | Harvard Medical School, Harvard University |
| Services | |
| Standards | NCI-designated Cancer Center |
| Speciality | Oncology, Teaching hospital |
| Helipad | Yes |
| History | |
| Opened | 1947 |
| Links | |
| Website | www |
| Lists | Hospitals in Massachusetts |
As of 2023, Dana-Farber is ranked the #4 cancer hospital in the world. Two Nobel laureates in Physiology or Medicine are among its past and present faculty. Dana-Farber's research discoveries include the development of the highly successful Gleevec to treat chronic myeloid leukemia.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.